Albumin versus Crystalloid Therapy in the Management of Hepatorenal Syndrome: A Model for using Meta Analysis in Cost Effectiveness Studies and the Design of Clinical Trials
You must log in to view this content. All contents are accessible to AMIA members and meeting attendees. If you are interested in purchasing proceedings, please contact us at mail@amia.org